Entering text into the input field will update the search result below

Health Care Select SPDR ETF Continues To Look Attractive

Geoff Considine profile picture
Geoff Considine


  • XLV has outperformed the broader market over the past 15 years.
  • There is a solid outlook for continued growth.
  • Healthcare stocks tend to provide some protection from market declines due to relatively low betas.
  • The market-implied outlook for XLV (calculated from options prices) is modestly bullish, albeit with higher expected volatility than in recent years.

Heart Health Concept

Eoneren/E+ via Getty Images

The Health Care Sector SPDR (NYSEARCA:XLV) holds the S&P 500 components that are in the healthcare sector. The allocation to each stock is a modified market cap weighting. Over the past 12 months, XLV

This article was written by

Geoff Considine profile picture
Geoff has worked in quantitative finance for more than twenty years. Before entering finance, Geoff was a research scientist for NASA. Geoff holds a PhD in Atmospheric Science from the University of Colorado - Boulder and a BS in Physics from Georgia Tech. Neither Geoff Considine nor Quantext (Geoff's company) are investment advisors. Nothing in any commentary here on Seeking Alpha or elsewhere shall be regarded as advice.

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

Comments (3)

Disagree with this article? Submit your own. To report a factual error in this article, . Your feedback matters to us!
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.